BJBMS becomes Biomolecules and Biomedicine

We are excited to annouce the title change of BJBMS from January 2023.
Find out more about this change in our Blog story, Editorial and the Frequently asked questions.

New Impact Factor (2022) for Biomolecules and Biomedicine is 3.4

Read about our new impact factor, performace metrics, and reviewers in a Blog story.

Latest articles

BJBMS continuously publishes highly relevant and trending articles in the Advanced online section.
Check out the list of the most recently published articles here.

S1P/S1PR signaling pathway advancements in autoimmune diseases

Ma et al.
Read more

Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing reactive oxygen species, endoplasmic reticulum stress, and Pannexin-1-mediated ferroptosis

Sun et al.
Read more

New and emerging methods
Validation of Doi’s weighted average glucose as a measure of post-load glucose excursion for clinical use

Badran et al.
Read more

Cannabinoids in cancer treatment: Therapeutic potential and legislation

Barbara Daris, Mojca Tancer Verboten, Zeljko Knez, Polonca Ferk
Read more

Photo Credits: Almir Hukic, Birds of Bosnia

Biomolecules and Biomedicine (formerly the Bosnian Journal of Basic Medical Sciences, BJBMS) is a comprehensive, multidisciplinary open-access medical journal dedicated to the advancement of medical research, practice, and education. The journal publishes pioneering research across the spectrum of pre-clinical studies, translational medicine, and clinical research, thereby advancing our collective knowledge in the realm of health and disease.
Find more information about the scope and aim here...

Edited by: Muzafer Mujic, MD, PhD and Semir Vranic, MD, PhD
Journal Impact Factor® (2022): 3.4
5-year Journal Impact Factor®: 3.6
CiteScore® (2022): 5.3
ISSN: 2831-0896 (Print)
ISSN: 2831-090X (Online)
Open Access
Frequency: Continuously published online. Six printed issues per year.
Published by: The Association of Basic Medical Sciences of FBIH

> Journal indexing and metrics
> Why publish with us?



The Reviewer of the Month for June 2024: Gehan Mohamed Hammad, PhD


Peer review is crucial in maintaining the quality and accuracy of scientific research. Each month, the BiomolBiomed Editorial team honors a reviewer for their exceptional feedback on manuscripts.

This month, we recognize Gehan Mohamed Hammad, PhD, from the Faculty of Biotechnology at October University for Modern Sciences and Arts in Giza, Egypt. Dr. Hammad’s reviews are notably thorough, offering authors valuable insights that enhance their work’s clarity and rigor.

We spoke with Dr. Hammad to discuss her peer-review philosophy and her perspective on the publishing industry. She shared her research interests and commented on recent developments and challenges in her field. Here are some highlights from our conversation:

Dr. Hammad, could you elaborate on your research interests and discuss any significant recent advances or ongoing challenges in your area?

Read more about The Reviewer of the Month for June 2024: Gehan Mohamed Hammad, PhD

Current Issue

Vol. 24 No. 3 (2024)
Published: 02-05-2024

Molecular Biology


New and Emerging Medical Entities

View All Issues